<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="2-part\PMC6958466\results\search\drugs\results.xml">
  <result pre="The structure of ZIKV MTase with the S-adenosyl-L-methionine (SAM) analog," exact="sinefungin" post="was recently elucidated. In the structural elucidation, Hercik et"/>
  <result pre="Hercik et al. proposed that designing of an inhibitor connecting" exact="sinefungin" post="with a Cap analog through a linker could provide"/>
  <result pre="ZIKV (EC50 = 142.9 mg/mL) [126]. However, poor inhibition of" exact="ribavirin" post="as shown in the above virus-induced CPE study indicates"/>
  <result pre="further development particularly as antivirals against ZIKV [127]. BCX4430 an" exact="adenosine" post="nucleoside analog has shown EC50 values in the low"/>
  <result pre="safety and better efficacy evaluations. Another RdRp inhibitor, NITD008, an" exact="adenosine" post="nucleoside analog, has also exhibited antiviral activity against ZIKV"/>
  <result pre="identify nine that could inhibit ZIKV replication. Among these inhibitors," exact="seliciclib" post="(a purine analog, also known as roscovitine) and RGB-286147"/>
  <result pre="the hypothesis by demonstrating anti-ZIKV activities of compounds such as" exact="warfarin" post="and a few similar structural analogues identified using in"/>
  <result pre="based on the measurement of intracellular viral RNA [95]. Incidentally," exact="niclosamide" post="is an FDA-approved drug, mainly used in the treatment"/>
  <result pre="unfolded protein response and autophagyFront. Microbiol.201451710.3389/fmicb.2014.0026624478763 140.KuivanenS.BespalovM.M.NandaniaJ.IanevskiA.VelagapudiV.De BrabanderJ.K.KainovD.E.VapalahtiO.Obatoclax, saliphenylhalamide and" exact="gemcitabine" post="inhibit Zika virus infection in vitro and differentially affect"/>
  <result pre="congenital microcephaly in miceEBioMedicine20172418919410.1016/j.ebiom.2017.09.03429033372 156.ShiryaevS.A.MesciP.PintoA.FernandesI.SheetsN.ShrestaS.FarhyC.HuangC.-T.StronginA.Y.MuotriA.R.et al.Repurposing of the anti-malaria drug" exact="chloroquine" post="for Zika virus treatment and prophylaxisSci. Rep.201771577110.1038/s41598-017-15467-629150641 157.HanY.MespledeT.XuH.QuanY.WainbergM.A.The antimalarial"/>
  <result pre="for Zika virus treatment and prophylaxisSci. Rep.201771577110.1038/s41598-017-15467-629150641 157.HanY.MespledeT.XuH.QuanY.WainbergM.A.The antimalarial drug" exact="amodiaquine" post="possesses anti-ZIKA virus activitiesJ. Med. Virol.20189079680210.1002/jmv.2503129315671 158.ZhouT.TanL.CederquistG.Y.FanY.HartleyB.J.MukherjeeS.TomishimaM.BrennandK.J.ZhangQ.SchwartzR.E.et al.High-content screening"/>
  <result pre="in vitro plaque assay [104] NITD008 A type of nucleoside" exact="adenosine" post="analog [105] Warfarin and a few similar structural analogues"/>
  <result pre="[93,95] Lovastatin and Mevastatin HMG-CoA reductase inhibitor [112] BCX4430 An" exact="adenosine" post="nucleoside analog, functions as a selective inhibitor of viral"/>
 </snippets>
</snippetsTree>
